Albano L et al. |
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. |
2013 |
Transplantation |
pmid:23982340
|
Cacciarelli TV et al. |
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1999 |
Transplantation |
pmid:10507484
|
Keenan RJ et al. |
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. |
1991 |
Transplantation |
pmid:1719668
|
Marcos A et al. |
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. |
2004 |
Transplantation |
pmid:15480160
|
Jain A et al. |
Pregnancy after liver transplantation under tacrolimus. |
1997 |
Transplantation |
pmid:9293865
|
Burroughs TE et al. |
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. |
2007 |
Transplantation |
pmid:17452891
|
Vincenti F |
A decade of progress in kidney transplantation. |
2004 |
Transplantation |
pmid:15201687
|
Shirakata Y et al. |
Inhibitory effect of plasma FKBP12 on immunosuppressive activity of FK506. |
1995 |
Transplantation |
pmid:8545894
|
Burke GW et al. |
Advances in pancreas transplantation. |
2004 |
Transplantation |
pmid:15201688
|
Garrity ER and Mehra MR |
An update on clinical outcomes in heart and lung transplantation. |
2004 |
Transplantation |
pmid:15201689
|
Pfitzmann R et al. |
Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. |
2003 |
Transplantation |
pmid:12865798
|
First MR and Fitzsimmons WE |
New drugs to improve transplant outcomes. |
2004 |
Transplantation |
pmid:15201693
|
Méndez A et al. |
Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation. |
2014 |
Transplantation |
pmid:24492423
|
Moss MC et al. |
Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? |
2014 |
Transplantation |
pmid:24492429
|
Fridell JA et al. |
Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. |
2006 |
Transplantation |
pmid:16906038
|
Boldt A et al. |
The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo. |
2006 |
Transplantation |
pmid:16906043
|
Narayanan M et al. |
Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression. |
2013 |
Transplantation |
pmid:23423268
|
Sheikh AM et al. |
Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. |
1999 |
Transplantation |
pmid:10440408
|
Gaber AO et al. |
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal. |
2013 |
Transplantation |
pmid:23423269
|
Moffatt SD et al. |
Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model. |
1999 |
Transplantation |
pmid:10342309
|
Fujita T et al. |
Prolonged survival of rat skin allograft by treatment with FK506 ointment. |
1997 |
Transplantation |
pmid:9326422
|
Yoshihara S et al. |
Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation. |
2004 |
Transplantation |
pmid:15077022
|
Krentz AJ et al. |
Postoperative glucose metabolism in liver transplant recipients. A two-year prospective randomized study of cyclosporine versus FK506. |
1994 |
Transplantation |
pmid:7516590
|
Jain AB et al. |
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. |
2004 |
Transplantation |
pmid:15077034
|
Briggs D et al. |
Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients. |
2003 |
Transplantation |
pmid:12829912
|
Jain A et al. |
Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. |
2014 |
Transplantation |
pmid:25285953
|
Utsugi R et al. |
Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. |
2001 |
Transplantation |
pmid:11391221
|
Murase N et al. |
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. |
1990 |
Transplantation |
pmid:1696405
|
Yin DP et al. |
Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. |
2001 |
Transplantation |
pmid:11391223
|
Krentz AJ |
Posttransplantation Diabetes Mellitus in FK-506-Treated Renal Transplant Recipients: Analysis of Incidence and Risk Factors. Transplantation 2001; 72: 1655. |
2001 |
Transplantation |
pmid:11726815
|
Bruce DS et al. |
Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. |
2001 |
Transplantation |
pmid:11726823
|
Maes BD et al. |
Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. |
2001 |
Transplantation |
pmid:11726827
|
Kahan BD |
An immunosuppressive triumvirate to minimize renal injuries associated with calcineurin antagonist therapy. |
1999 |
Transplantation |
pmid:10428260
|
Washburn K et al. |
Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil. |
2001 |
Transplantation |
pmid:11726831
|
Moxey-Mims MM et al. |
Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) |
1998 |
Transplantation |
pmid:9521193
|
Sanchez-Campos S et al. |
Cholestasis and alterations of glutathione metabolism induced by tacrolimus (FK506) in the rat. |
1998 |
Transplantation |
pmid:9679826
|
Hytiroglou P et al. |
FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations. |
1993 |
Transplantation |
pmid:7506452
|
Egeland EJ et al. |
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation. |
2017 |
Transplantation |
pmid:28452920
|
Hsiau M et al. |
Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. |
2011 |
Transplantation |
pmid:21857278
|
Yates CJ et al. |
Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin. |
2013 |
Transplantation |
pmid:23902993
|
Storb R et al. |
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. |
1993 |
Transplantation |
pmid:7692635
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Tabasco-Minguillan J et al. |
Insulin requirements after liver transplantation and FK-506 immunosuppression. |
1993 |
Transplantation |
pmid:7692637
|
Jordan ML et al. |
Long-term results of pancreas transplantation under tacrolius immunosuppression. |
1999 |
Transplantation |
pmid:10075592
|
Kaplan B et al. |
Frequency of hyperkalemia in recipients of simultaneous pancreas and kidney transplants with bladder drainage. |
1996 |
Transplantation |
pmid:8900321
|
Min DI et al. |
Circadian variation of tacrolimus disposition in liver allograft recipients. |
1996 |
Transplantation |
pmid:8900327
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis. |
2011 |
Transplantation |
pmid:21107305
|
Bronster DJ et al. |
Tacrolimus-associated mutism after orthotopic liver transplantation. |
2000 |
Transplantation |
pmid:11014653
|
Jindal RM et al. |
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7519799
|
Newell KA et al. |
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. |
1996 |
Transplantation |
pmid:8779685
|
Lufft V et al. |
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. |
1996 |
Transplantation |
pmid:8779695
|
Reddy KS et al. |
Simultaneous kidney-pancreas transplantation without antilymphocyte induction. |
2000 |
Transplantation |
pmid:10653379
|
Nobori S et al. |
Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. |
2006 |
Transplantation |
pmid:16421473
|
Yu S et al. |
Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. |
2006 |
Transplantation |
pmid:16421475
|
Borrows R et al. |
Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16421488
|
Muraki T et al. |
Effects of cyclosporine and FK506 on in vitro high shear-induced platelet reactivity in rat and human non-anticoagulated blood. |
1998 |
Transplantation |
pmid:9583878
|
Kadry Z et al. |
Kaposi's sarcoma in liver transplant recipients on FK506. |
1998 |
Transplantation |
pmid:9583882
|
Luan FL et al. |
New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. |
2011 |
Transplantation |
pmid:21242885
|
Ho ET et al. |
Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review. |
2013 |
Transplantation |
pmid:23542469
|
Shapiro R et al. |
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. |
2008 |
Transplantation |
pmid:18431232
|
Porrini E et al. |
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. |
2008 |
Transplantation |
pmid:18431233
|
Veroux M et al. |
Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications. |
2012 |
Transplantation |
pmid:22298033
|
Naesens M et al. |
Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. |
2008 |
Transplantation |
pmid:18431234
|
Dean PG et al. |
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. |
2008 |
Transplantation |
pmid:18431244
|
Laskow DA et al. |
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. |
1996 |
Transplantation |
pmid:8878381
|
Shoji T et al. |
Operational tolerance to class I disparate lungs can be induced despite pretransplant immunization with class I allopeptides. |
2007 |
Transplantation |
pmid:18091523
|
Woodle ES et al. |
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. |
1996 |
Transplantation |
pmid:8878382
|
Inoue T et al. |
Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. |
2000 |
Transplantation |
pmid:11003356
|
McLaren A |
Tacrolimus pharmacogenetics: bringing the laboratory into the clinic. |
2003 |
Transplantation |
pmid:14705621
|
Tanaka A et al. |
Living related liver transplantation across ABO blood groups. |
1994 |
Transplantation |
pmid:7522363
|
Roberts CA et al. |
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. |
2002 |
Transplantation |
pmid:12364862
|
Kessler L et al. |
Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen. |
2006 |
Transplantation |
pmid:16495816
|
Holt S and Moore K |
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. |
2002 |
Transplantation |
pmid:11907407
|
Yang H et al. |
Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model. |
2002 |
Transplantation |
pmid:11907415
|
Klein IH et al. |
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. |
2002 |
Transplantation |
pmid:11907418
|
St A Nunes FA and Lucey MR |
Searching for a balance when applying immunosuppression after liver transplantation. |
2001 |
Transplantation |
pmid:11258425
|
Ringe B et al. |
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. |
2001 |
Transplantation |
pmid:11258429
|
Meiser BM |
The best dosing for initial tacrolimus application is trough level adapted! |
2005 |
Transplantation |
pmid:15714162
|
Podesser BK et al. |
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study. |
2005 |
Transplantation |
pmid:15714171
|
Taylor-Fishwick DA et al. |
Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use. |
1993 |
Transplantation |
pmid:7689258
|
Cantarovich D et al. |
Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events. |
2005 |
Transplantation |
pmid:15714172
|
Nguyen L et al. |
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients. |
2012 |
Transplantation |
pmid:22960763
|
Apanay DC et al. |
Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. |
1994 |
Transplantation |
pmid:7524202
|
Steinmüller TM et al. |
The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial. |
1994 |
Transplantation |
pmid:7524203
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Thomas PG et al. |
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. |
2007 |
Transplantation |
pmid:17565326
|
Sonoda T et al. |
Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in japan. |
2003 |
Transplantation |
pmid:12548123
|
Guthery SL et al. |
Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. |
2003 |
Transplantation |
pmid:12698085
|
Jain A et al. |
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. |
2003 |
Transplantation |
pmid:12698091
|
Egashira K et al. |
Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. |
2003 |
Transplantation |
pmid:12698101
|
Hu H et al. |
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. |
2003 |
Transplantation |
pmid:12698107
|
Fredericks S and Holt DW |
TGF-beta quantitation can be tricky. |
1999 |
Transplantation |
pmid:10480399
|
Peng Y et al. |
Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. |
2013 |
Transplantation |
pmid:23263506
|
Warty V et al. |
FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes. |
1988 |
Transplantation |
pmid:2458643
|
Kuypers DR et al. |
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. |
2013 |
Transplantation |
pmid:23263559
|
Hewitt CW and Black KS |
Comparative studies of FK506 with cyclosporine. |
1988 |
Transplantation |
pmid:2458644
|
White M et al. |
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. |
2006 |
Transplantation |
pmid:17006323
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Chan L et al. |
Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients. |
2010 |
Transplantation |
pmid:20517177
|
Talento A et al. |
A single administration of LFA-1 antibody confers prolonged allograft survival. |
1993 |
Transplantation |
pmid:7679531
|